(Kessler, 1986). Such factors may include other sexually transmitted infections (zur Hausen, 1989). Although the etiologic link between herpes simplex virus-2 (HSV-2) and cervical cancer had been proposed over 2 decades ago, recent studies have highlighted the significance and importance of this association. The role for HSV-2 infection in cervical cancer has been based primarily on sero-epidemiological data and on detection of HSV antigens in exfoliated cells from patients with cervical dysplasia and cancer. The difficulty in establishing a definitive association has been compounded by the lack of persistence of HSV sequences in neoplastic cervical lesions. In fact, a 1984 prospective case-control study (Vonka et al., 1984) did not report such an association, which was later suggested to have resulted from overmatching of the cohort of women for sexual activity that minimized risk factors (Reeves et al., 1989). In other studies, the lack of correlation of HSV-2 with cervical cancer was attributed to screening for virus-specific immunoglobulin G, instead of immunoglobulin A, as a marker for the presence of HSV-2. A case-control study using confirmed histological cases of cervical cancer from Latin America found that the presence of HSV-2 antibodies correlated with a 9-fold excess risk of cervical cancer compared with women negative for HSV-2 or HPV-16/18 (Hildesheim et al., 1991). In other well-controlled studies of cervical cancer, a 2-to 4-fold excess cancer risk has been reported for HSV-2 seropositive women (Slattery et al., 1989). Finally, in a case-control study (Daling et al., 1996) involving women from western Washington state, the potential cofactors with HPVs in the development of cervical cancer were analyzed. A significant increase in risk associated with HSV-2, as measured by antibodies, was found only in women whose tumor biopsies were negative for HPV. One major problem in establishing a definitive link between HSV-2 and cervical cancer has been the inability to consistently detect HSV-2-specific DNA in cervical cancer biopsy samples despite the fact that investigators have reported the presence of herpes-virusspecific sequences in some of the carcinoma tissues analyzed (Di Luca et al., 1987;Park et al., 1983).Experimental support for a role of HSV-2 in cervical cancer has come from in vitro studies that demonstrated its transforming potential using inactivated virus (Macnab, 1974) or viral subfragments, MTR II (BglII N) and BglII C (MTR III) (Galloway and McDougall, 1981;Reyes et al., 1979). However, the elucidation of the mechanism(s) leading to the transformed phenotype was complicated by the loss of viral sequences suggesting a hit and run mechanism (Galloway and McDougall, 1983). Our studies on the transforming potential and the retention of BglII N and its subfragments on NIH 3T3 cells have suggested that BglII N, when present in its entirety, has a toxic effect resulting from either a high copy number or from specific functions(s) expressed by its coding sequences (Saavedra and Kessous-Elba...